Patents by Inventor William Bubnis
William Bubnis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11419938Abstract: An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% glycerin and up to about 10% sorbitol wherein the glycerin to sorbitol ratio is about 2:1 to 10:1.Type: GrantFiled: July 19, 2017Date of Patent: August 23, 2022Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS LLCInventors: Amanda R Alley, William A Bubnis, Stephanie Shield
-
Patent number: 11406712Abstract: An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% glycerin and up to about 10% sorbitol wherein the glycerin to sorbitol ratio is about 2:1 to 10:1.Type: GrantFiled: March 12, 2019Date of Patent: August 9, 2022Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS LLCInventors: Amanda R Alley, William A Bubnis, Stephanie Shield
-
Publication number: 20190209688Abstract: An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% glycerin and up to about 10% sorbitol wherein the glycerin to sorbitol ratio is about 2:1 to 10:1.Type: ApplicationFiled: March 12, 2019Publication date: July 11, 2019Applicant: Wyeth LLCInventors: Amanda R. Alley, William A. Bubnis, Stephanie Shield
-
Publication number: 20170333561Abstract: An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% glycerin and up to about 10% sorbitol wherein the glycerin to sorbitol ratio is about 2:1 to 10:1.Type: ApplicationFiled: July 19, 2017Publication date: November 23, 2017Applicant: Wyeth LLCInventors: Amanda R. Alley, William A. Bubnis, Stephanie Shield
-
Patent number: 9801941Abstract: An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% glycerin and up to about 10% sorbitol wherein the glycerin to sorbitol ratio is about 2:1 to 10:1.Type: GrantFiled: December 12, 2014Date of Patent: October 31, 2017Assignee: Wyeth LLCInventors: Amanda Alley, William Bubnis, Stephanie Shield
-
Publication number: 20150150976Abstract: An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% glycerin and up to about 10% sorbitol wherein the glycerin to sorbitol ratio is about 2:1 to 10:1.Type: ApplicationFiled: December 12, 2014Publication date: June 4, 2015Inventors: Amanda Alley, William Bubnis, Stephanie Shield
-
Patent number: 8968768Abstract: The invention provides a nutritional supplement which includes phytosterol to facilitate reduction of cholesterol. The nutritional supplement may be a swallowable tablet, chewable tablet, sachet, capsule or suspension. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized swallowable tablet and a method for reducing blood cholesterol in humans.Type: GrantFiled: September 28, 2005Date of Patent: March 3, 2015Assignee: Wyeth LLCInventors: Scott W. Poxon, William Bubnis, Bruce W. Sutton, Jeffrey V. Vernon, Denise L. Walters, Michael G. Williams, Neil Wittenberg
-
Patent number: 8940796Abstract: An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% w/v glycerin and up to about 10% w/v sorbitol wherein the glycerin to sorbitol ratio is about 2:1 to 10:1.Type: GrantFiled: February 9, 2007Date of Patent: January 27, 2015Assignee: Wyeth LLCInventors: William Bubnis, Stephanie Shield, Amanda Alley
-
Patent number: 8927012Abstract: The invention provides a nutritional supplement which includes micronutrients to facilitate reduction of cholesterol, and/or reduction of homocystein and/or reduction of low-density lipoprotein-cholesterol (LDL-C) oxidation in humans. In one embodiment the supplement is a multi-vitamin, a mineral supplement which includes at least one component known to reduce cholesterol. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized tablet and a method for reducing blood cholesterol in humans.Type: GrantFiled: September 19, 2013Date of Patent: January 6, 2015Assignee: Wyeth LLCInventors: William Bubnis, Richard Cotter, Paul W. Herman, Judith Moreines, Scott W. Poxon, Bruce W. Sutton, Jeffrey V. Vernon, Denise L. Walters, Michael G. Williams, Neil Wittenberg
-
Publication number: 20140017312Abstract: The invention provides a nutritional supplement which includes micronutrients to facilitate reduction of cholesterol, and/or reduction of homocystein and/or reduction of low-density lipoprotein-cholesterol (LDL-C) oxidation in humans. In one embodiment the supplement is a multi-vitamin, a mineral supplement which includes at least one component known to reduce cholesterol. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized tablet and a method for reducing blood cholesterol in humans.Type: ApplicationFiled: September 19, 2013Publication date: January 16, 2014Applicant: Wyeth LLCInventors: William Bubnis, Richard Cotter, Paul W. Herman, Judith Moreines, Scott W. Poxon, Bruce W. Sutton, Jeffrey V. Vernon, Denise L. Walters, Michael G. Williams, Neil Wittenberg
-
Publication number: 20120296081Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more carrageenans, including lambda carrageenan. Also disclosed are methods for making and using the compositions.Type: ApplicationFiled: July 31, 2012Publication date: November 22, 2012Inventors: William R. Blakemore, Arthur D. Ballard, Christopher J. Sewall, James J. Modliszewski, William A. Bubnis
-
Publication number: 20110223250Abstract: The invention provides a nutritional supplement which includes micronutrients to facilitate reduction of cholesterol, and/or reduction of homocystein and/or reduction of low-density lipoprotein-cholesterol (LDL-C) oxidation in humans. In one embodiment the supplement is a multi-vitamin, a mineral supplement which includes at least one component known to reduce cholesterol. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized tablet and a method for reducing blood cholesterol in humans.Type: ApplicationFiled: February 9, 2011Publication date: September 15, 2011Applicant: Wyeth LLCInventors: William Bubnis, Richard Cotter, Paul W. Herman, Judith Moreines, Scott W. Poxon, Bruce W. Sutton, Jeffrey V. Vernon, Denise L. Walters, Michael G. Williams, Neil Wittenberg
-
Publication number: 20080161551Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more carrageenans, including lambda carrageenan. Also disclosed are methods for making and using the compositions.Type: ApplicationFiled: December 21, 2007Publication date: July 3, 2008Inventors: William R. Blakemore, Arthur D. Ballard, Christopher J. Sewall, James J. Modliszowski, William A. Bubnis
-
Publication number: 20080014274Abstract: An oral, liquid pharmaceutical composition is provided. The composition comprises phenylephrine and substantially aldehyde-free polyethylene glycol. The composition has phenylephrine stability compatible with the stability required for commercial preparations. Optionally, the composition may comprise one or more additional active agents.Type: ApplicationFiled: July 14, 2006Publication date: January 17, 2008Applicant: WyethInventors: William Bubnis, Stephanie Shield, Gayle P. Hoskovec
-
Publication number: 20070197661Abstract: An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% w/v glycerin and up to about 10% w/v sorbitol wherein the glycerin to sorbitol ratio is about 2:1 to 10:1.Type: ApplicationFiled: February 9, 2007Publication date: August 23, 2007Applicant: WyethInventors: William Bubnis, Stephanie Shield, Amanda Alley
-
Publication number: 20060024352Abstract: The invention provides a nutritional supplement which includes phytosterol to facilitate reduction of cholesterol. The nutritional supplement may be a swallowable tablet, chewable tablet, sachet, capsule or suspension. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized swallowable tablet and a method for reducing blood cholesterol in humans.Type: ApplicationFiled: September 28, 2005Publication date: February 2, 2006Inventors: Scott Poxon, William Bubnis, Bruce Sutton, Jeffrey Vernon, Denise Walters, Michael Williams, Neil Wittenberg
-
Publication number: 20050214383Abstract: The invention provides a nutritional supplement which includes micronutrients to facilitate reduction of cholesterol, and/or reduction of homocystein and/or reduction of low-density lipoprotein-cholesterol (LDL-C) oxidation in humans. In one embodiment the supplement is a multi-vitamin, a mineral supplement which includes at least one component known to reduce cholesterol. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized tablet and a method for reducing blood cholesterol in humans.Type: ApplicationFiled: March 28, 2005Publication date: September 29, 2005Inventors: William Bubnis, Richard Cotter, Paul Herman, Judith Moreines, Scott Poxon, Bruce Sutton, Jeffrey Vernon, Denise Walters, Michael Williams, Neil Wittenberg
-
Publication number: 20050171053Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more carrageenans, including lambda carrageenan. Also disclosed are methods for making and using the compositions.Type: ApplicationFiled: October 29, 2004Publication date: August 4, 2005Applicant: FMC CorporationInventors: William Blakemore, Arthur Ballard, Christopher Sewall, James Modliszewski, William Bubnis